Effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis
We investigated the effectiveness of Copaxone in patients with relapsing-remitting multiple sclerosis for 3 and 5 years. Significant improvement found the decrease of the frequency of clinical exacerbations and delay the accumulation of physical disability during treatment period.
Principais autores: | , , |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Siberian State Medical University (Tomsk)
2010-08-01
|
coleção: | Бюллетень сибирской медицины |
Assuntos: | |
Acesso em linha: | https://bulletin.ssmu.ru/jour/article/view/1618 |